Article Text
Abstract
Posterior cortical atrophy (PCA) is a neurodegenerative syndrome dominated by deterioration of higher visual function (particularly visuospatial and visuoperceptual abilities). It is most commonly due to Alzheimer's disease pathology, but may also be caused by dementia with Lewy bodies, corticobasal degeneration or Creutzfeldt-Jakob disease. Patients often present to optometrists, ophthalmologists and/or neurologists with non-specific visual complaints, and unless clinicians seek the specific symptoms and signs of PCA (beyond that of the ‘standard’ neurological examination), this infrequent disorder is easily missed, delaying its diagnosis and treatment. We review the clinical features of PCA, focusing on its visual manifestations, to help neurologists recognise this important syndrome.
- Posterior Cortical Atrophy
- Balint's syndrome
- Simultanagnosia
- Alzheimer's disease
- Neuro-ophthalmology
Statistics from Altmetric.com
Supplementary materials
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data supplement 1 - Online references
Linked Articles
- Editors' commentary
- Editorial
Other content recommended for you
- Here, there and everywhere: higher visual function and the dorsal visual stream
- The language profile of posterior cortical atrophy
- Down syndrome with posterior cortical atrophy
- Qualitative, exploratory pilot study to investigate how people living with posterior cortical atrophy, their carers and clinicians experience tests used to assess vision
- Case of posterior cortical atrophy (PCA) evolved to PCA-CBS
- The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer’s disease) with FDG-PET
- Psychoanatomical substrates of Bálint's syndrome
- Homonymous hemianopia as the presenting sign of posterior cortical atrophy
- Clinical assessment of parietal lobe function
- Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias